WAIVER AND TERMINATION AGREEMENTWaiver and Termination Agreement • September 8th, 2003 • Open Joint Stock Co Vimpel Communications • Radiotelephone communications • New York
Contract Type FiledSeptember 8th, 2003 Company Industry JurisdictionThis WAIVER AND TERMINATION AGREEMENT (this “Agreement”), dated as of the 28th day of August, 2003, by and among OPEN JOINT STOCK COMPANY “VIMPEL-COMMUNICATIONS”, an open joint stock company organized and existing under the laws of the Russian Federation (“VIP”), ECO TELECOM LIMITED, a company organized and existing under the laws of Gibraltar (“Eco Telecom”), TELENOR EAST INVEST AS, a company organized and existing under the laws of Norway (“Telenor”) and OPEN JOINT STOCK COMPANY “VIMPELCOM-REGION”, an open joint stock company organized and existing under the laws of the Russian Federation (“VIP-R”).
WAIVER AND TERMINATION AGREEMENTWaiver and Termination Agreement • December 14th, 2007 • SOI Holdings, Inc. • Services-help supply services • New York
Contract Type FiledDecember 14th, 2007 Company Industry JurisdictionTHIS WAIVER AND TERMINATION AGREEMENT (“Agreement”) is dated as of the 27th day of August, 2007, by and between Clarion Operating, LLC (“Clarion”) and SOI Holdings, Inc. (“SOI” and together with Clarion, the “Parties”).
WAIVER AND TERMINATION AGREEMENTWaiver and Termination Agreement • March 5th, 2009 • American Tower Corp /Ma/ • Communications services, nec • Massachusetts
Contract Type FiledMarch 5th, 2009 Company Industry JurisdictionThis Waiver and Termination Agreement (this “Agreement”) is executed as of this day of March 2009 by and between American Tower Corporation, a Delaware corporation and its subsidiaries and affiliates (collectively the “Company”) and (“Employee,” and together with the Company, the “Parties,” and each, a “Party”).
WAIVER AND TERMINATION AGREEMENT DATED 8 NOVEMBER, 2002 (THE “EFFECTIVE DATE”)Waiver and Termination Agreement • March 31st, 2003 • Depomed Inc • Pharmaceutical preparations
Contract Type FiledMarch 31st, 2003 Company IndustryWhereas, Elan Corporation, plc, an Irish public limited company (“Elan”), DepoMed, Inc., a California corporation (the “Company”), Elan Pharma International Limited, a private limited company incorporated under the laws of Ireland (“EPIL”), and DepoMed Development Ltd., a Bermuda exempted limited liability company (“Newco”), entered into a License Agreement, dated January 21, 2000 (the “Elan License Agreement”), which set forth the terms and conditions of a license from Elan to Newco of certain intellectual property of Elan.
APRIL 20 2006 ___________________________________________________________________ SHARE PURCHASE AGREEMENT ___________________________________________________________________Waiver and Termination Agreement • April 28th, 2006 • Infosys Technologies LTD • Services-computer programming services
Contract Type FiledApril 28th, 2006 Company IndustryNOW, THEREFORE, in consideration of these presents and the mutual agreements herein and for other good and valuable consideration, the receipt and adequacy of which are hereby acknowledged, the parties hereto, intending to be legally bound by the terms hereof applicable to each of them, hereby agree as follows:
Waiver and Termination AgreementWaiver and Termination Agreement • August 5th, 2020 • Newell Brands Inc. • Plastics products, nec
Contract Type FiledAugust 5th, 2020 Company IndustryBy signature below, the undersigned “Executive” acknowledges and agrees with Newell Brands Inc. (the “Company”) that the Newell Brands Executive Severance Plan (the “Plan”), effective July 26, 2019, replaces and supersedes, and the Executive hereby waives, any rights to severance payments and other severance benefits under any employment security agreement (“ESA”) or other written agreement between Executive and the Company and/or any of its Affiliates in effect as of the effective date of Executive’s participation in the Plan (other than any provisions thereof that apply to Executive’s awards with respect to the securities of Newell that were granted prior to the effective date of Executive’s participation in the Plan); provided that, notwithstanding any other provision of the Plan, all of Executive’s awards with respect to the securities of the Company that are still outstanding upon the date of Executive’s termination of employment and that were granted prior to the date Executive s
February 18, 2014 Letter Agreement Re: Post-Repurchase TermsWaiver and Termination Agreement • March 3rd, 2014 • MediWound Ltd. • Medicinal chemicals & botanical products
Contract Type FiledMarch 3rd, 2014 Company IndustryThis shall serve to confirm the agreements between Teva Pharmaceutical Industries Ltd. (“Teva”) and MediWound Ltd. (“MediWound”) with respect to the matters set forth below:
WAIVER AND TERMINATION AGREEMENTWaiver and Termination Agreement • November 16th, 2018 • Fortress Biotech, Inc. • Pharmaceutical preparations • Delaware
Contract Type FiledNovember 16th, 2018 Company Industry JurisdictionTHIS WAIVER AND TERMINATION AGREEMENT (as may be amended or modified from time to time, this “Agreement”) is entered into on November 12, 2018, by and among Fortress Biotech, Inc., a Delaware corporation (“Fortress”), Avenue Therapeutics, Inc., a Delaware corporation (the “Company”), and InvaGen Pharmaceuticals Inc., a New York corporation (“Buyer”).